Key Events This Week
2 Mar: Stock opens at Rs.1,337.20, declines 1.06% amid broad market weakness
4 Mar: Technical momentum shifts amid mixed signals; stock plunges 8.63%
5 Mar: Downgrade to Sell rating announced; technical downshift confirmed
6 Mar: Week closes at Rs.1,252.05, down 0.10% on the day

3B Blackbio DX Ltd Downgraded to Sell Amid Mixed Financials and Bearish Technicals
2026-03-05 08:21:183B Blackbio DX Ltd, a key player in the Healthcare Services sector, has seen its investment rating downgraded from Hold to Sell as of 4 March 2026. This shift reflects a combination of deteriorating technical indicators, challenging long-term financial trends, and valuation concerns despite recent positive quarterly results. The company’s Mojo Score now stands at 47.0, signalling a Sell recommendation, marking a significant change in investor sentiment.
Read full news article
3B Blackbio DX Ltd Faces Technical Downshift Amidst Bearish Momentum
2026-03-05 08:01:363B Blackbio DX Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, signalling a transition from a sideways trend to a mildly bearish stance. This change is underscored by a series of mixed technical indicators, including bearish MACD and Bollinger Bands on weekly and monthly charts, alongside mildly bullish daily moving averages. The stock’s recent price action and technical signals suggest caution for investors amid heightened volatility and downward pressure.
Read full news article
3B Blackbio DX Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-03-04 08:02:223B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a modest day gain of 0.33%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This article analyses these developments in detail, placing them in the context of the company’s recent performance and broader market trends.
Read full news article










